Edelman, M. J., Hodgson, L., Wang, X., Kratzke, R. A., & Vokes, E. E. (2012). Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer. American Society of Clinical Oncology.

Edelman, Martin J., Lydia Hodgson, Xiaofei Wang, Robert A. Kratzke, and Everett E. Vokes. Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer. American Society of Clinical Oncology, 2012.

Edelman, Martin J., et al. Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer. American Society of Clinical Oncology, 2012.